BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 36073634)

  • 1. Effects of Nicorandil Administration on Infarct Size in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial.
    Qian G; Zhang Y; Dong W; Jiang ZC; Li T; Cheng LQ; Zou YT; Jiang XS; Zhou H; A X; Li P; Chen ML; Su X; Tian JW; Shi B; Li ZZ; Wu YQ; Li YJ; Chen YD
    J Am Heart Assoc; 2022 Sep; 11(18):e026232. PubMed ID: 36073634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of nicorandil on cardiac function and clinical outcomes in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a randomised trial.
    Choe JC; Oh JH; Lee HC; Lee JW; Park TS; Park JH; Kim E; Kim MS; Ahn J; Park JS; Lee HW; Choi JH; Cha KS
    Acta Cardiol; 2023 Oct; 78(8):880-888. PubMed ID: 36942830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial.
    Gwag HB; Kim EK; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Lee SH; Chang SA; Park SJ; Lee SC; Park SW; Jang WJ; Lee M; Chun WJ; Oh JH; Park YH; Choe YH; Gwon HC; Hahn JY
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).
    Pasupathy S; Tavella R; Grover S; Raman B; Procter NEK; Du YT; Mahadavan G; Stafford I; Heresztyn T; Holmes A; Zeitz C; Arstall M; Selvanayagam J; Horowitz JD; Beltrame JF
    Circulation; 2017 Sep; 136(10):894-903. PubMed ID: 28634219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction.
    Chen WR; Chen YD; Tian F; Yang N; Cheng LQ; Hu SY; Wang J; Yang JJ; Wang SF; Gu XF
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 9. Gradual Versus Abrupt Reperfusion During Primary Percutaneous Coronary Interventions in ST-Segment-Elevation Myocardial Infarction (GUARD).
    Sezer M; Escaned J; Broyd CJ; Umman B; Bugra Z; Ozcan I; Sonsoz MR; Ozcan A; Atici A; Aslanger E; Sezer ZI; Davies JE; van Royen N; Umman S
    J Am Heart Assoc; 2022 May; 11(10):e024172. PubMed ID: 35574948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    Traverse JH; Swingen CM; Henry TD; Fox J; Wang YL; Chavez IJ; Lips DL; Lesser JR; Pedersen WR; Burke NM; Pai A; Lindberg JL; Garberich RF
    Circ Res; 2019 Mar; 124(5):769-778. PubMed ID: 30602360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Atrial Fibrillation During ST-Segment-Elevation Myocardial Infarction on Infarct Characteristics and Prognosis.
    Reinstadler SJ; Stiermaier T; Eitel C; Fuernau G; Saad M; Pöss J; de Waha S; Mende M; Desch S; Metzler B; Thiele H; Eitel I
    Circ Cardiovasc Imaging; 2018 Feb; 11(2):e006955. PubMed ID: 29391346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Nepper-Christensen L; Lønborg J; Ahtarovski KA; Høfsten DE; Kyhl K; Ghotbi AA; Schoos MM; Göransson C; Bertelsen L; Køber L; Helqvist S; Pedersen F; Saünamaki K; Jørgensen E; Kelbæk H; Holmvang L; Vejlstrup N; Engstrøm T
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28069574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous nicorandil during primary percutaneous coronary intervention in patients with ST-Elevation myocardial infarction: Rationale and design of the Clinical Efficacy and Safety of Intravenous Nicorandil (CLEAN) trial.
    Huang D; Wu H; Zhou J; Zhong X; Gao W; Ma Y; Qian J; Ge J
    Am Heart J; 2022 Feb; 244():86-93. PubMed ID: 34785173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Immediate With Delayed Stenting Using the Minimalist Immediate Mechanical Intervention Approach in Acute ST-Segment-Elevation Myocardial Infarction: The MIMI Study.
    Belle L; Motreff P; Mangin L; Rangé G; Marcaggi X; Marie A; Ferrier N; Dubreuil O; Zemour G; Souteyrand G; Caussin C; Amabile N; Isaaz K; Dauphin R; Koning R; Robin C; Faurie B; Bonello L; Champin S; Delhaye C; Cuilleret F; Mewton N; Genty C; Viallon M; Bosson JL; Croisille P;
    Circ Cardiovasc Interv; 2016 Mar; 9(3):e003388. PubMed ID: 26957418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single Bolus r-SAK Before Primary PCI for ST-Segment-Elevation Myocardial Infarction.
    Chen P; Eikelboom JW; Tan C; Zhang W; Xu Y; Bai J; Wang J; Wang T; Gong X; Liu K; Chen X; Wang X; Zhu L; Zhao X; Yang N; Jiang J; Pu J; Zhao B; Chen Z; Li B; Wang G; Lu C; Ying L; Jiang M; Zhu X; Ma J; Dong Z; Li C; Zong J; Zhang F; Zhu J; Huang J; Kong X; Yu H; Li C;
    Circ Cardiovasc Interv; 2024 Feb; 17(2):e013455. PubMed ID: 38258563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study.
    Khan JN; Greenwood JP; Nazir SA; Lai FY; Dalby M; Curzen N; Hetherington S; Kelly DJ; Blackman D; Peebles C; Wong J; Flather M; Swanton H; Gershlick AH; McCann GP
    J Am Heart Assoc; 2016 May; 5(6):. PubMed ID: 27247336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized Prognosis Assessment in ST-Segment-Elevation Myocardial Infarction Using a Cardiac Magnetic Resonance Imaging Risk Score.
    Stiermaier T; Jobs A; de Waha S; Fuernau G; Pöss J; Desch S; Thiele H; Eitel I
    Circ Cardiovasc Imaging; 2017 Nov; 10(11):. PubMed ID: 29122844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Trimetazidine Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction Reduces Myocardial Infarction Size.
    Qian G; A X; Jiang X; Jiang Z; Li T; Dong W; Guo J; Chen Y
    Cardiovasc Drugs Ther; 2023 Jun; 37(3):497-506. PubMed ID: 34767131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.
    Roolvink V; Ibáñez B; Ottervanger JP; Pizarro G; van Royen N; Mateos A; Dambrink JE; Escalera N; Lipsic E; Albarran A; Fernández-Ortiz A; Fernández-Avilés F; Goicolea J; Botas J; Remkes W; Hernandez-Jaras V; Kedhi E; Zamorano JL; Navarro F; Alfonso F; García-Lledó A; Alonso J; van Leeuwen M; Nijveldt R; Postma S; Kolkman E; Gosselink M; de Smet B; Rasoul S; Piek JJ; Fuster V; van 't Hof AWJ;
    J Am Coll Cardiol; 2016 Jun; 67(23):2705-2715. PubMed ID: 27050189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Prognostic Utility of Indexes of Microvascular Function Alone or in Combination in Patients With an Acute ST-Segment-Elevation Myocardial Infarction.
    Carrick D; Haig C; Ahmed N; Carberry J; Yue May VT; McEntegart M; Petrie MC; Eteiba H; Lindsay M; Hood S; Watkins S; Davie A; Mahrous A; Mordi I; Ford I; Radjenovic A; Oldroyd KG; Berry C
    Circulation; 2016 Dec; 134(23):1833-1847. PubMed ID: 27803036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.